Editorial
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Feb 27, 2023; 15(2): 123-128
Published online Feb 27, 2023. doi: 10.4254/wjh.v15.i2.123
Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate
Yasser Fouad
Yasser Fouad, Department of Gastroenterology and Endemic Medicine, Minia University, Minia 19111, Egypt
Author contributions: Fouad Y wrote and revised the editorial.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yasser Fouad, MD, Professor, Department of Gastroenterology and Endemic Medicine, Minia University, El Omoumy Rd., ARD SHALABY, EL MENIA, Minia 19111, Egypt. yasserfouad10@yahoo.com
Received: August 29, 2022
Peer-review started: August 29, 2022
First decision: November 17, 2022
Revised: November 19, 2022
Accepted: January 31, 2023
Article in press: January 31, 2023
Published online: February 27, 2023
Processing time: 178 Days and 20.5 Hours
Core Tip

Core Tip: An international panel recently proposed an update to the terminology and diagnostic criteria for fatty liver disease. The authors proposed a change in the nomenclature from non-alcoholic fatty liver disease (NAFLD) to metabolic (dysfunction)-associated fatty liver disease (MAFLD). Several studies have been published recently, and showed tremendous evidence of the superiority of MAFLD criteria over NAFLD criteria. Consequently, many societies, physician and nurse groups, health stakeholders, representatives of regulatory sciences, and others endorsed the new nomenclature.